What does a mildly reduced diffusing capacity of the lung for carbon monoxide (DLCO) indicate on pulmonary function testing (PFT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Does Mild DLCO Mean in PFT?

A mild DLCO reduction means your diffusing capacity is greater than 60% of predicted but below the lower limit of normal (LLN), indicating early or less severe impairment in the lung's ability to transfer gas from the alveoli to the bloodstream. 1

Severity Classification

According to the European Respiratory Society guidelines, DLCO reductions are graded as follows 1:

  • Mild: >60% predicted AND <LLN
  • Moderate: 40-60% predicted
  • Severe: <40% predicted

Clinical Interpretation Depends on Context

The meaning of a mild DLCO reduction must be interpreted alongside spirometry and lung volumes to narrow the differential diagnosis 1:

With Normal Spirometry and Lung Volumes

A mildly reduced DLCO suggests 1:

  • Anemia (check hemoglobin - DLCO adjustments for hemoglobin are critical)
  • Early emphysema (particularly in smokers)
  • Pulmonary vascular disorders (early pulmonary hypertension, chronic pulmonary embolism)
  • Early interstitial lung disease (ILD)

With Airflow Obstruction (Low FEV1/FVC)

A mildly reduced DLCO strongly suggests 1, 2:

  • Emphysema phenotype of COPD (in smokers with post-bronchodilator obstruction, low DLCO greatly increases probability of emphysema)
  • Normal DLCO in this context makes chronic asthma more likely

With Restriction (Low FVC, Normal FEV1/FVC)

  • Low DLCO: Increases probability of interstitial lung disease 1, 2
  • Normal DLCO: Makes chest wall or neuromuscular restriction more likely

Important Adjustments and Caveats

Always adjust DLCO for hemoglobin and carboxyhaemoglobin levels 1, especially when:

  • Monitoring for drug toxicity
  • Patients undergoing chemotherapy (hemoglobin fluctuates)
  • Evaluating smokers (elevated carboxyhaemoglobin)

Common pitfall: Do not use DLCO/VA (KCO) to "normalize" DLCO for lung volume - this relationship is not linear and can be misleading 1. Instead, examine DLCO/VA and VA separately for pathophysiologic insights.

Clinical Significance

Even mild DLCO reductions have clinical importance 3:

  • Associated with increased COPD symptoms, reduced exercise performance, and higher severe exacerbation risk
  • Every 10% predicted decrease in DLCO correlates with worse quality of life scores and reduced 6-minute walk distance
  • DLCO <40% predicted or decline >4 units is associated with increased morbidity and mortality 2

A mild reduction warrants investigation for underlying causes, particularly when symptoms are present 4, as it may represent early disease requiring intervention or closer monitoring.

Related Questions

What are the possible causes and recommended workup for a patient with a normal FEV1/FVC ratio, normal FEV1 and FVC, but a reduced diffusing capacity of the lungs for carbon monoxide (DLCO)?
What does a low diffusing capacity of the lung for carbon monoxide (DLCO) and low DLCO/VA indicate?
What is the significance and management of a reduced Diffusing Capacity of the Lung for Carbon Monoxide (DLCO)?
Why should we measure KCO (transfer coefficient for carbon monoxide) in addition to DLCO (diffusing capacity of the lung for carbon monoxide) rather than relying on DLCO alone?
What is the interpretation of pulmonary function test results with DLCO uncorrected 70% predicted, DLCO corrected 67% predicted, alveolar volume (VA) 92% predicted, and KCO 72% predicted, and what further evaluation is recommended?
Can tuberculosis medications cause atopic dermatitis?
How should I manage a hypotensive patient with a heart rate of about 50 bpm, active rheumatoid arthritis flare, multiple infections, a dilated aortic root measuring 5.1 cm, who is taking ramipril?
Can oral anti‑diabetic agents be used in a hospitalized patient with a non‑healing wound?
What is the appropriate management of insomnia in an older adult with dementia?
What is the appropriate management for a diabetic patient with a blood glucose of 37 mg/dL?
In an 83‑year‑old woman with Alzheimer’s disease, mild mixed dementia, major depressive disorder, insomnia, aphasia, and vitamin D deficiency who is now exhibiting evening‑time paranoid accusations (sundowning) and has a negative urine culture, what is the likely cause of her psychosis and what medication is recommended for treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.